Recent insider trading activity from Compton John G., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Compton John G. | Director | C | Common Stock | 7669 | $0.00 | 14,335.0000 | 0 | 115.05% | 0.00% |
| Feb. 19, 2026 | 20/20 Biolabs, Inc. | $AIDX | Compton John G. | Director | C | Series A-2 Preferred Stock | 7669 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |